Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments

Yutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo-Saito, Nobuo Tsukamoto, Tomoko Iwata-Kajihara, Shoko Nakamura, Hiroshi Nishio, Ryosuke Satomi, Asuka Kobayashi, Mayuri Tanaka, Jeong Hoon Park, Hajime Kamijuku, Takahiro Tsujikawa, Naoshi Kawamura

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Cancer cells trigger multiple immunosuppressive cascades and generate immunosuppressive tumor-associated microenvironments including tumor and sentinel lymph nodes. Constitutive activation of various signaling pathways (e.g., MAPK, STAT3, NF-κB, β-catenin) in human cancer cells was found to trigger the multiple immunosuppressive cascades through the production of immunosuppressive cytokines, such as TGF-β, IL-10, IL-6, and VEGF, and induction of immunosuppressive immune cells, such as regulatory T cells, tolerogenic dendritic cells, and myeloid derived suppressor cells. Some of these cancer-derived cytokines impair various immune cells through activation of their signaling molecules such as STAT3 and NF-κB. Inhibitors for these activated signals could inhibit the multiple immunosuppressive cascades by acting on both cancer cells and immune cells. Since common signaling mechanisms are often utilized for some of the hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression), targeting these common signaling pathways may be an attractive strategy for cancer therapy, including immunotherapy.

Original languageEnglish
Title of host publicationThe Tumor Immunoenvironment
PublisherSpringer Netherlands
Pages307-323
Number of pages17
ISBN (Print)9789400762176, 940076216X, 9789400762169
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Tumor Microenvironment
Immunosuppressive Agents
Neoplasms
Cytokines
Catenins
Regulatory T-Lymphocytes
Interleukin-10
Immunotherapy
Immunosuppression
Dendritic Cells
Vascular Endothelial Growth Factor A
Interleukin-6
Cell Survival
Cell Proliferation
Neoplasm Metastasis

Keywords

  • BRAF
  • IL-10
  • Immunosuppression
  • MAPK
  • MDSC
  • NF-κB
  • Regulatory T cells
  • STAT3
  • TGF-β
  • β-catenin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kawakami, Y., Yaguchi, T., Sumimoto, H., Kudo-Saito, C., Tsukamoto, N., Iwata-Kajihara, T., ... Kawamura, N. (2014). Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments. In The Tumor Immunoenvironment (pp. 307-323). Springer Netherlands. https://doi.org/10.1007/978-94-007-6217-6_12

Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments. / Kawakami, Yutaka; Yaguchi, Tomonori; Sumimoto, Hidetoshi; Kudo-Saito, Chie; Tsukamoto, Nobuo; Iwata-Kajihara, Tomoko; Nakamura, Shoko; Nishio, Hiroshi; Satomi, Ryosuke; Kobayashi, Asuka; Tanaka, Mayuri; Park, Jeong Hoon; Kamijuku, Hajime; Tsujikawa, Takahiro; Kawamura, Naoshi.

The Tumor Immunoenvironment. Springer Netherlands, 2014. p. 307-323.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kawakami, Y, Yaguchi, T, Sumimoto, H, Kudo-Saito, C, Tsukamoto, N, Iwata-Kajihara, T, Nakamura, S, Nishio, H, Satomi, R, Kobayashi, A, Tanaka, M, Park, JH, Kamijuku, H, Tsujikawa, T & Kawamura, N 2014, Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments. in The Tumor Immunoenvironment. Springer Netherlands, pp. 307-323. https://doi.org/10.1007/978-94-007-6217-6_12
Kawakami Y, Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Iwata-Kajihara T et al. Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments. In The Tumor Immunoenvironment. Springer Netherlands. 2014. p. 307-323 https://doi.org/10.1007/978-94-007-6217-6_12
Kawakami, Yutaka ; Yaguchi, Tomonori ; Sumimoto, Hidetoshi ; Kudo-Saito, Chie ; Tsukamoto, Nobuo ; Iwata-Kajihara, Tomoko ; Nakamura, Shoko ; Nishio, Hiroshi ; Satomi, Ryosuke ; Kobayashi, Asuka ; Tanaka, Mayuri ; Park, Jeong Hoon ; Kamijuku, Hajime ; Tsujikawa, Takahiro ; Kawamura, Naoshi. / Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments. The Tumor Immunoenvironment. Springer Netherlands, 2014. pp. 307-323
@inbook{40db5a15a93041d1939d7d2261bc89ff,
title = "Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments",
abstract = "Cancer cells trigger multiple immunosuppressive cascades and generate immunosuppressive tumor-associated microenvironments including tumor and sentinel lymph nodes. Constitutive activation of various signaling pathways (e.g., MAPK, STAT3, NF-κB, β-catenin) in human cancer cells was found to trigger the multiple immunosuppressive cascades through the production of immunosuppressive cytokines, such as TGF-β, IL-10, IL-6, and VEGF, and induction of immunosuppressive immune cells, such as regulatory T cells, tolerogenic dendritic cells, and myeloid derived suppressor cells. Some of these cancer-derived cytokines impair various immune cells through activation of their signaling molecules such as STAT3 and NF-κB. Inhibitors for these activated signals could inhibit the multiple immunosuppressive cascades by acting on both cancer cells and immune cells. Since common signaling mechanisms are often utilized for some of the hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression), targeting these common signaling pathways may be an attractive strategy for cancer therapy, including immunotherapy.",
keywords = "BRAF, IL-10, Immunosuppression, MAPK, MDSC, NF-κB, Regulatory T cells, STAT3, TGF-β, β-catenin",
author = "Yutaka Kawakami and Tomonori Yaguchi and Hidetoshi Sumimoto and Chie Kudo-Saito and Nobuo Tsukamoto and Tomoko Iwata-Kajihara and Shoko Nakamura and Hiroshi Nishio and Ryosuke Satomi and Asuka Kobayashi and Mayuri Tanaka and Park, {Jeong Hoon} and Hajime Kamijuku and Takahiro Tsujikawa and Naoshi Kawamura",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-94-007-6217-6_12",
language = "English",
isbn = "9789400762176",
pages = "307--323",
booktitle = "The Tumor Immunoenvironment",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments

AU - Kawakami, Yutaka

AU - Yaguchi, Tomonori

AU - Sumimoto, Hidetoshi

AU - Kudo-Saito, Chie

AU - Tsukamoto, Nobuo

AU - Iwata-Kajihara, Tomoko

AU - Nakamura, Shoko

AU - Nishio, Hiroshi

AU - Satomi, Ryosuke

AU - Kobayashi, Asuka

AU - Tanaka, Mayuri

AU - Park, Jeong Hoon

AU - Kamijuku, Hajime

AU - Tsujikawa, Takahiro

AU - Kawamura, Naoshi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cancer cells trigger multiple immunosuppressive cascades and generate immunosuppressive tumor-associated microenvironments including tumor and sentinel lymph nodes. Constitutive activation of various signaling pathways (e.g., MAPK, STAT3, NF-κB, β-catenin) in human cancer cells was found to trigger the multiple immunosuppressive cascades through the production of immunosuppressive cytokines, such as TGF-β, IL-10, IL-6, and VEGF, and induction of immunosuppressive immune cells, such as regulatory T cells, tolerogenic dendritic cells, and myeloid derived suppressor cells. Some of these cancer-derived cytokines impair various immune cells through activation of their signaling molecules such as STAT3 and NF-κB. Inhibitors for these activated signals could inhibit the multiple immunosuppressive cascades by acting on both cancer cells and immune cells. Since common signaling mechanisms are often utilized for some of the hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression), targeting these common signaling pathways may be an attractive strategy for cancer therapy, including immunotherapy.

AB - Cancer cells trigger multiple immunosuppressive cascades and generate immunosuppressive tumor-associated microenvironments including tumor and sentinel lymph nodes. Constitutive activation of various signaling pathways (e.g., MAPK, STAT3, NF-κB, β-catenin) in human cancer cells was found to trigger the multiple immunosuppressive cascades through the production of immunosuppressive cytokines, such as TGF-β, IL-10, IL-6, and VEGF, and induction of immunosuppressive immune cells, such as regulatory T cells, tolerogenic dendritic cells, and myeloid derived suppressor cells. Some of these cancer-derived cytokines impair various immune cells through activation of their signaling molecules such as STAT3 and NF-κB. Inhibitors for these activated signals could inhibit the multiple immunosuppressive cascades by acting on both cancer cells and immune cells. Since common signaling mechanisms are often utilized for some of the hallmarks of cancer (e.g., cell proliferation/survival, invasion/metastasis, and immunosuppression), targeting these common signaling pathways may be an attractive strategy for cancer therapy, including immunotherapy.

KW - BRAF

KW - IL-10

KW - Immunosuppression

KW - MAPK

KW - MDSC

KW - NF-κB

KW - Regulatory T cells

KW - STAT3

KW - TGF-β

KW - β-catenin

UR - http://www.scopus.com/inward/record.url?scp=84932165409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932165409&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-6217-6_12

DO - 10.1007/978-94-007-6217-6_12

M3 - Chapter

AN - SCOPUS:84932165409

SN - 9789400762176

SN - 940076216X

SN - 9789400762169

SP - 307

EP - 323

BT - The Tumor Immunoenvironment

PB - Springer Netherlands

ER -